Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 3
1966 1
1968 1
1970 1
1971 2
1972 2
1975 2
1976 1
1978 2
1979 1
1980 2
1983 1
1984 1
1986 1
1987 3
1988 5
1989 1
1990 4
1991 2
1992 4
1993 6
1994 8
1995 8
1996 9
1997 8
1998 15
1999 7
2000 11
2001 15
2002 14
2003 29
2004 41
2005 35
2006 39
2007 47
2008 56
2009 60
2010 51
2011 69
2012 93
2013 82
2014 100
2015 93
2016 98
2017 107
2018 124
2019 141
2020 208
2021 231
2022 236
2023 230
2024 202

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,254 results

Results by year

Filters applied: . Clear all
Page 1
mRNA vaccine quality analysis using RNA sequencing.
Gunter HM, Idrisoglu S, Singh S, Han DJ, Ariens E, Peters JR, Wong T, Cheetham SW, Xu J, Rai SK, Feldman R, Herbert A, Marcellin E, Tropee R, Munro T, Mercer TR. Gunter HM, et al. Among authors: rai sk. Nat Commun. 2023 Sep 21;14(1):5663. doi: 10.1038/s41467-023-41354-y. Nat Commun. 2023. PMID: 37735471 Free PMC article.
Targeted degradation of the enhancer lysine acetyltransferases CBP and p300.
Vannam R, Sayilgan J, Ojeda S, Karakyriakou B, Hu E, Kreuzer J, Morris R, Herrera Lopez XI, Rai S, Haas W, Lawrence M, Ott CJ. Vannam R, et al. Among authors: rai s. Cell Chem Biol. 2021 Apr 15;28(4):503-514.e12. doi: 10.1016/j.chembiol.2020.12.004. Epub 2021 Jan 4. Cell Chem Biol. 2021. PMID: 33400925 Free article.
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results.
Rai S, Kim WS, Ando K, Choi I, Izutsu K, Tsukamoto N, Yokoyama M, Tsukasaki K, Kuroda J, Ando J, Hidaka M, Koh Y, Shibayama H, Uchida T, Yang DH, Ishitsuka K, Ishizawa K, Kim JS, Lee HG, Minami H, Eom HS, Kurosawa M, Lee JH, Lee JS, Lee WS, Nagai H, Shindo T, Yoon DH, Yoshida S, Gillings M, Onogi H, Tobinai K. Rai S, et al. Haematologica. 2023 Mar 1;108(3):811-821. doi: 10.3324/haematol.2022.280996. Haematologica. 2023. PMID: 36200417 Free PMC article.
A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B-cell lymphoma.
Terui Y, Rai S, Izutsu K, Yamaguchi M, Takizawa J, Kuroda J, Ishikawa T, Kato K, Suehiro Y, Fukuhara N, Ohmine K, Goto H, Yamamoto K, Kanemura N, Ueda Y, Ishizawa K, Kumagai K, Kawasaki A, Saito T, Hashizume M, Shibayama H. Terui Y, et al. Among authors: rai s. Cancer Sci. 2021 Jul;112(7):2845-2854. doi: 10.1111/cas.14937. Epub 2021 Jun 4. Cancer Sci. 2021. PMID: 33942442 Free PMC article. Clinical Trial.
Exploring the potential impact of GLP-1 receptor agonists in cancer therapy.
Aslam B, Bin Zafar MD, Changez MIK, Abdullah M, Safwan M, Qamar B, Shinwari A, Rai S. Aslam B, et al. Among authors: rai s. Minerva Endocrinol (Torino). 2023 Dec 21. doi: 10.23736/S2724-6507.23.04101-5. Online ahead of print. Minerva Endocrinol (Torino). 2023. PMID: 38127407
2,254 results